PEMERIKSAAN FUNGSI ENDOTEL PADA PENYAKIT KARDIOVASKULAR
Abstract
Cardiovascular risk factors have been known to play a role in vascular endothelial damage. Endothelial damage can cause a condition called endothelial dysfunction. Endothelial dysfunction is the initial process of various cardiovascular problems such as coronary heart disease, stroke, peripheral artery disease, and others. Early stage endothelial damage can actually be detected, but often patients present at the stage of cardiovascular problems. Various examinations of endothelial function start from invasive, non invasive, until biomarkers marking the occurrence of dysfunction can be done. So that we can prevent or reduce the occurrence of further damage
Keywords
Full Text:
PDFReferences
Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction a marker of atherosclerotic risk, Arterioscler Thromb Vasc Biol, AHA, 2003; 168-175.
Wierzbicki AS, Chowienczyk PJ, Cockcroft JR, et al. Cardiovascular risk factors and endothelial dysfunction, Biochem Soc Great Britain, 2004;(107): 609–15.
Sharaf B, Pepine CJ, Kerensky RA, et al. WISE Study Group. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001;87(8):937–41.
Widmer RJ, Lerman A. Endothelial dysfunction and cardiovascular disease, Glob Card Sci Pract 2014;43.
Chhabra N. Endothelial dysfunction: a predictor of atherosclerosis, Int J Med Update, 2009;4(1):33-41.
Park KH, Park WJ. Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches, J Korean Med Sci 2015; 30: 1213-25.
Darwin E, Elfi EF, Elvira D. Endotel: fungsi dan disfungsi, Padang : Andalas University Press, 2017;90-2.
Deanfield JE. Endothelial function and dysfunction : Testing and Clinical Relevance, Circ, AHA, 2007; 1285-95.
Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice, Circ. 2012;126:753-67.
Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 2006;315:1046–51.
Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circ. 2000;101:I899–1906.
Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circ. 2000;101:948–54.
Beltrame JF, Crea F, Camici P. Advances in coronary microvascular dysfunction. Heart Lung Circ. 2009;18:19–27.
Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830–40.
Mittal SR. Diagnosis of coronary microvascular dysfunction – present status, Indian Heart Journal. 2015; 67:552–60.
Betik AC, Luckham VB, Hughson RL. Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol 2004; 286:442.
Yeboah J, Folsom AR, Burke GL. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circ 2009; 120:502.
Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging 2010; 26: 631.
Thijssen DH, Black MA, Pyke KE. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011; 2:300.
Walker HA, Jackson G, Ritter JM, Chowienczyk PJ. Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement. Br J Clin Pharmacol. 2001; 51(3): 225–229.
Halcox JPJ, Schenke WH, Zalos G. Prognostic value of coronary vascular endothelial dysfunction. Circ. 2002;106:653–658.
Heitzer T, Schlinzig T, Krohn K. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circ. 2001;104:2673–2678.
Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003;146:168–74.
Nohria A, Gerhard-Herman M, Creager MA, et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006;101:545–48.
Teixeira BC, Lopes AL, Macedo RCO, et al. Inflammatory markers, endothelial function and cardiovascular risk, J Vasc Bras, 2014; 13(2):108-15.
Welsh P, Preiss D, Tsiropoulou S, et al. Biomarkers of vascular inflammation and cardiovascular disease, Springer, 2015; 115-29.
DOI: http://dx.doi.org/10.32883/hcj.v5i3.817
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
HUMAN CARE JOURNAL
Published by Universitas Fort De Kock, Bukittinggi, Indonesia
© Human Care Journal e-ISSN : 2528-665X P-ISSN : 2685-5798